Summary
Glycation of long-lived proteins is an inevitable consequence of aging that is accelerated in patients with diabetes mellitus. Treatment of demineralized bone matrix particles from 35-week-old normal Long-Evans rats with glycolaldehyde, a precursor of advanced glycation end-products, was used to assess the effects of bone-matrix glycation on the process of bone differentiation. Matrix was incubated in phosphate buffered saline alone, phosphate buffered saline containing glycolaldehyde, glycolaldehyde plus the advanced glycation product-inhibitor aminoguanidine, or glycolaldehyde plus the advanced glycation product-inhibitor sodium cyanoborohydride. Glycolaldehyde increased the matrix advanced glycation product content as measured by specific fluorescence more than two-fold, while inhibiting bone differentiation more than 90 % as measured by in vivo 45CaCl2 uptake, alkaline phosphatase levels, and histology. In contrast, simultaneous incubation with the advanced glycation product-inhibitor aminoguanidine or sodium cyanoborohydride not only reduced fluorescence to normal, but also restored bone differentiation. Furthermore, the inhibition of bone differentiation by glycolaldehyde was not reversed by subsequent application of recombinant bone morphogenetic protein-2. These observations suggest that formation of advanced glycation products on bone matrix alters its ability to induce bone formation, and probably involves alterations of binding sites for extractable proteins with direct bone inductive properties such as bone morphogenetic protein-2. Decreased bone formation associated with aging and diabetes may result, in part, from advanced glycation product formation on matrix proteins.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Francis RM (1990) Osteoporosis: pathogenesis and management. Kluwer Academic Publishers, Boston
Herbsman H (1968) Retardation of fracture healing in experimental diabetes. J Surg Res 8: 424–431
Herbsman H, Kwon K, Shafton GW, Gordon B, Fox LM, Enquist IF (1966) The influence of systemic factors on fracture healing. J Trauma 6: 75–78
Wray JB, Stunkle E (1965) The effect of experimental diabetes upon the breaking strength of healing fracture in the rat. J Surg Res 5: 479–481
Cozen L (1972) Does diabetes delay fracture healing? Clin Orthop 82: 134–140
Lips P, Courpron P, Meuneir PJ (1978) Mean wall thickness of trabecular bone packets in human iliac crest: changes with age. Calcif Tissue Res 26: 13–17
Nordin BEC, Aaron J, Speed R, Crilly RG (1981) Bone formation and resorption as the determinants of trabecular bone volume in post-menopausal osteoporosis. Lancet II: 277–279
Levin ME, Boisseau VC, Avioli LV (1976) Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med 294: 241–245
Klein J, Frost HM, Sedlin ED (1963) Lamellar bone physiology in diabetes mellitus: mesenchymal cell activation function and haversian canal formation kinetics. Diabetes 12: 362A (Abstract)
Wu K, Schobeck KE, Frost HM, Villaneveva A (1970) Haversian bone formation rates determined by a new method in a mastodon, and in human diabetes mellitus and osteoporosis. Calcif Tissue Res 6: 204–219
Benveniste R, Bixler D, Conneally PM (1967) Peridontal disease in diabetics. J Periodontal 38: 271–279
Finestone AJ, Boorujy SR (1967) Diabetes mellitus and periodontal disease. Diabetes 16: 336–340
Fargacs S, Halmos T, Salumon F (1972) Bone changes in diabetes mellitus. Isr J Med Sci 782–783
Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A (1986) Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking. Science 232: 1629–1632
Schnider SL, Kohn RR (1981) Effect of age and diabetes mellitus on the solubility and non-enzymatic glycosylation of human skin collagen. J Clin Invest 67: 1630–1635
Schnider SL, Kohn RR (1981) Glycosylation of human collagen in aging and diabetes mellitus. J Clin Invest 67: 1179–1181
Tsilbary EC, Charonis AS, Reger LA, Wohlhueter RM, Furtht LT (1988) The effect of nonenzymatic glycosylation on the binding of the main noncollagenous NC1 domain to type IV collagen. J Biol Chem 263: 4302–4308
Charonis AS, Reger LA, Dege JE et al. (1990) Laminin alterations after in vitro nonenzymatic glucosylation. Diabetes 39: 807–814
Tsilibary EC, Charonis AS (1990) The effect of nonenzymatic glucosylation on cell and heparin-binding microdomains from type IV collagen and laminin. Diabetes 39: 194 A (Abstract)
Haitglou CS, Tsilibary EC, Brownlee M, Charonis AS (1992) Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen. J Biol Chem 267: 12404–12407
Kleinman H, Klebe RJ, Martin GR (1981) Role of collagenous matrices in the adhesion and growth of cells. J Cell Biol 88: 473–485
Urist MR (1965) Bone: formation by autoinduction. Science 150: 893–899
Weiss RE, Reddi AH (1980) Influence of experimental diabetes and insulin on matrix-induced cartilage and bone differentiation. Am J Physiol 238: E200-E207
Sampath TK, Reddi AH (1981) Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci USA 78: 7599–7603
Wang EA, Rosen V, D'Alessandro JS et al. (1990) Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87: 2220–2224
Acharya AS, Manning JM (1983) Reaction of glycoaldehyde with proteins: latent crosslinking potential of alpha-hydroxyaldehydes. Proc Natl Acad Sci USA 80: 3590–3594
Bessey OA, Lowry OH, Brock MJ (1946) A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J Biol Chem 164: 321–329
Gitel HJ (1967) An improved automated procedure for the determination of calcium in biochemical specimen. Anal Biochem 18: 521–526
Brownlee M (1990) Advanced products of non-enzymatic glycosylation and the pathogenesis of diabetic complications. In: Rifkin H, Porte D (eds) Diabetes mellitus, theory and practice. Elsevier, New York, pp 279–291
Higgins PJ, Bunn HF (1981) Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. J Biol Chem 256:5204–5208
Brownlee M (1991) Glycosylation products as toxic mediators of diabetic complications. Ann Rev Med 42:159–166
Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315–1321
Monnier VM, Kohn RR, Cerami A (1984) Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 81:583–587
Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S (1992) Immunochemical evidence for the presence of advanced glycation end products in human lens protein and its positive correlation with aging. J Biol Chem 267:10211–10214
Reddi AH, Anderson WA (1976) Collagenous bone matrix-induced endochondral ossification and hematopoiesis. J Cell Biol 69: 557–572
Carrington JL, Chen R Yanagishita M, Reddi AH (1991) Osteogenin (bone morphogenetic protein-3) stimulates cartilage formation by chick limb bud cells in vitro. Dev Biol 146:406–415
Wozney JM, Rosen V, Celeste AJ et al. (1988) Novel regulators of bone formation: molecular clones and activities. Science 242: 1528–1534
Muthukumaran N, Ma S, Reddi AH (1988) Dose-dependence of and threshold for optimal bone induction by collagenous bone matrix and osteogenin-enriched fraction. Coll Relat Res 8: 433–441
Landesman R, Reddi AH (1985) Induction of endochondral bone by demineralized bone matrix from diabetic rats. Calcif Tissue Int 37:630–634
Edelstein D, Brownlee M (1992) Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41:26–29
Soules-Liparota T, Cooper M, Papzoglou D, Clarke B, Jerums G (1991) Retardation by aminoguanidine of development of albuminuria mesangial expansion and tissue fluorescence in streptozotocin induced diabetic rat. Diabetes 40:1328–1335
Edelstein D, Brownlee M (1992) Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats. Diabetologia 35: 96–97
Kihara M, Schmelzer JD, Poduslo JF, Curran GL, Nickander KK, Low PA (1991) Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology and oxygen free radicals. Proc Natl Acad Sci USA 88: 6107–6111
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fong, Y., Edelstein, D., Wang, E.A. et al. Inhibition of matrix-induced bone differentiation by advanced glycation end-products in rats. Diabetologia 36, 802–807 (1993). https://doi.org/10.1007/BF00400353
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400353